Insulin therapy is the cornerstone of medical treatment for many patients with diabetes. Self-administration of this life-saving medication is no longer limited to the traditional vial and syringe. Instead, more and more patients worldwide are using prefilled insulin pen devices. Ease of use, convenience, confidence in dosing accuracy, and improved quality of life are just a few of their advantages. As with any medical technology, safe and proper use is vital. Many studies have examined pen device preference and usability. Until now, no study has included patients with both visual and dexterity impairments. To ensure safe and simple self-administration of insulin for all patients, it is time for the special needs of patients with diabetes to be considered not only during product development, but during postmarketing studies as well.
PerfettiR. Reusable and disposable insulin pens for the treatment of diabetes: Understanding the global differences in user preference and an evaluation of inpatient insulin pen use. Diabetes Technol Ther.2010;12Suppl 1: S79–85
MeeceJ. Effect of insulin pen devices on the management of diabetes mellitus. Am J Health Syst Pharm.2008;65 (11): 1076–82.
7.
Da CostaSBrackenridgeBHicksD. A comparison of insulin pen use in the United States and the United Kingdom. Diabetes Educ.2002;28 (1): 52–6, 59–60.
8.
KorytkowskiMNiskanenLAsakuraT. FlexPen: Addressing issues of confidence and convenience in insulin delivery. Clin Ther.2005;27Suppl B: S89–100
9.
BohannonNJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med.1999;106 (5): 57–8, 61–4, 68.
10.
BohannonNJOhannesianJPBurdanALHolcombeJHZagarA. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther.2000;22 (9): 1049–67.
11.
StocklKOryCVanderplasANicklassonLLynessWCobdenDChangE. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin.2007;23 (1): 133–46.
12.
RubinRRPeyrotM. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care.2004;27 (10): 2495–7.
13.
CoscelliCLostiaSLunettaMNosariICoronelGA. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract.1995;28 (3): 173–7.
14.
GraffMRMcClanahanMA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther.1998;20 (3); 486–96.
15.
KorytkowskiMBellDJacobsenCSuwannasariR; FlexPen Study Team. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther.2003;25 (11): 2836–48.
16.
SummersKHSzeinbachSLLenoxSM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther.2004;26 (9); 1498–505.
17.
LeeWCBaluSCobdenDJoshiAVPashosCL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data. Clin Ther.2006;28 (10); 1712–25; discussion 1710–1.
18.
PawaskarMDCamachoFTAndersonRTCobdenDJoshiAVBalkrishnanR. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: A retrospective database analysis. Clin Ther.2007;29 Spec No: 1294–305.
AsakuraTSeinoH. Assessment of dose selection attributes with audible notification in insulin pen devices. Diabetes Technol Ther.2005;7 (4): 620–6.
22.
WilliamsASSchnarrenbergerPA. A comparison of dosing accuracy: Visually impaired and sighted people using insulin pens. J Diabetes Sci Technol.2010;4 (3): 514–21.
23.
Crude and Age-Adjusted Percentage of Adults with Diabetes Reporting Visual Impairment, United States, 1997–2010. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/statistics/visual/fig2.htm. Accessed May 8, 2012.
PfütznerASchipperCNiemeyerMQvistMLöfflerAForstTMusholtPB. Comparison of patient preference for two insulin injection pen devices in relation to patient dexterity. Two Insulin. J Diabetes Sci Technol.2012;6 (4): 910–6.
